|
By M.E.Garza
|
|
Thursday, 07 July 2016 07:10 |
 Jonathan Adams is CEO of NanoAntibiotics, Inc. (OTCQB:NNAB) [nanoantibiotics.com], which will soon change its name to BioVie.
|
|
Read more...
|
|
By Staff and Wire Reports
|
|
Monday, 16 November 2015 10:39 |
 Cellceutix Corporation (OTC: CTIX), reports, based upon ongoing laboratory studies, the Company intends to use docetaxel for the combination therapy arm in the planned Phase 2 clinical trial to treat patients with platinum-resistance ovarian cancer. Cellceutix is designing the multi-arm study to evaluate Kevetrin as a monotherapy and as a component of combination therapy.
|
|
Read more...
|
|
By Ghana News Agency
|
|
Sunday, 15 November 2015 15:32 |
 The Food and Drugs Authority (FDA) has approved a vaccine, namely the Johnson Ebola vaccine for clinical trials as part of international effort to find a cure to deadly Ebola Virus Disease (EVD). A second vaccine, the GSK vaccine, is currently being considered for approval.
|
|
Read more...
|
|
By Ben Hirschler - REUTERS
|
|
Saturday, 14 November 2015 03:45 |
 A new lung cancer pill from AstraZeneca , designed for patients whose disease has worsened after treatment with other therapies, won early U.S. approval on Friday, in a boost for the British drugmaker.
|
|
Read more...
|
|
By John Carroll - FierceBiotech
|
|
Tuesday, 10 November 2015 02:57 |
 Amgen is jumping back into the M&A game. And it's looking for another Onyx-sized deal that can deliver a late-stage drug ready to be hustled across the finish line.
|
|
Read more...
|
|
By CHERI CHENG - FDA News Today
|
|
Saturday, 07 November 2015 17:51 |
 The U.S. FDA has approved a new HIV pill that will make taking medications easier for HIV positive patients. The incurable infection, HIV (human immunodeficiency virus) leads to AIDS.
|
|
Read more...
|
|
By Staff and Wire Reports
|
|
Thursday, 05 November 2015 22:30 |
 Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved Genvoya® (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir alafenamide 10 mg or E/C/F/TAF) for the treatment of HIV-1 infection. Genvoya is the first TAF-based regimen to receive FDA approval.
|
|
Read more...
|
|
By FDAnews Drug Daily Bulletin
|
|
Thursday, 05 November 2015 11:37 |
 Pfizer is in preliminary talks to purchase part or all of Irish drugmaker Allergan, the two companies confirmed last week.
|
|
Read more...
|
|
By Staff and Wire Reports
|
|
Wednesday, 04 November 2015 14:47 |
 Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) announced the appointment of Dr. Xin Du, Ph.D., to the position of Executive Director, Regulatory Affairs and Dr. Sri Srivastava, Ph.D., PMP, to the position of Associate Director of Project Management.
|
|
Read more...
|
|
By Staff and Wire Reports
|
|
Monday, 02 November 2015 21:59 |
 Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today reported financial results for the third quarter 2015.
|
|
Read more...
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
|
Page 2 of 56 |
